← Evidence map

ArticleCureus2022

Predictors of the Outcomes Following the Tocilizumab Treatment for Severe COVID-19.

Karan Singla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36176874